You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 7,704,947


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,704,947 protect, and when does it expire?

Patent 7,704,947 protects LINZESS and is included in one NDA.

This patent has eighty-six patent family members in twenty-seven countries.

Summary for Patent: 7,704,947
Title:Methods and compositions for the treatment of gastrointestinal disorders
Abstract: The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), Crohn's disease, ulcerative colitis, Inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation, and constipation associated with neuropathic disorders as well as other conditions and disorders using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.
Inventor(s): Currie; Mark G. (Sterling, MA), Mahajan-Miklos; Shalina (Stanford, CA), Norman; Thea (San Diego, CA), Milne; G. Todd (Brookline, MA)
Assignee: Ironwood Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:11/930,696
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,704,947
Patent Claim Types:
see list of patent claims
Compound; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,704,947

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This article will delve into the details of United States Patent 7,704,947, exploring its claims, the patent landscape, and the implications for businesses and inventors.

Overview of the Patent

United States Patent 7,704,947, hereafter referred to as the '947 patent, is a specific patent that, like all patents, contains a set of claims that define the scope of the invention. These claims are the heart of the patent, as they delineate what is protected under the patent.

Claims Analysis

Types of Claims

Patent claims can be categorized into several types, including independent claims, dependent claims, and method claims. Independent claims stand alone and define the invention without reference to other claims. Dependent claims, on the other hand, refer back to and further limit an independent claim. Method claims describe a process or method of achieving a particular result[4].

Claims of the '947 Patent

The '947 patent includes multiple claims, each of which must be carefully analyzed to understand the full scope of the invention. For instance:

  • Claims 1-4 and 13-14: These claims might define the core invention, including any specific components, processes, or methods that are novel and non-obvious.
  • Claim Structure: Understanding the hierarchy of claims is essential. Independent claims set the broad scope, while dependent claims narrow it down, adding specific details or limitations.

Patentability Requirements

For any patent, including the '947 patent, the claims must meet several key requirements to be considered valid.

Novelty Requirement

The claimed invention must be new and not previously disclosed in the prior art. This means that every element of the claimed invention must not have been available to the public before the effective filing date of the patent application[4].

Nonobviousness Requirement

The invention must also be non-obvious, meaning it must be significantly different from existing knowledge and not an obvious combination of prior art elements. This is a critical test to ensure that the invention is truly innovative[4].

Subject Matter Eligibility

The patent claims must also be directed to eligible subject matter. This involves ensuring that the invention is not merely a law of nature, natural phenomenon, or abstract idea, unless it includes an inventive concept that transforms the ineligible subject matter into a patent-eligible application[4].

Patent Landscape Analysis

Competitor Patents

To fully understand the '947 patent, it is essential to analyze the broader patent landscape. This includes identifying competitor patents that may overlap or conflict with the claims of the '947 patent. Tools like patent analytics and claim charts can help in this process[3].

Claim Coverage Matrix

A Claim Coverage Matrix can be used to categorize patents by claims and scope concepts. This helps in identifying which patents and claims are actively protecting the intellectual property and where gaps or opportunities exist. For the '947 patent, such a matrix would highlight the specific areas covered by its claims and how they relate to other patents in the same field[3].

Scope Concepts

The scope concepts of the patent claims are critical in determining their value. These concepts can be categorized as high, medium, or low value based on their current and future relevance to the company. This categorization helps in strategic decision-making regarding patent maintenance and future development directions[3].

Legal and Regulatory Considerations

Obviousness-Type Double Patenting (ODP)

ODP is a concept that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of Patent Term Adjustment (PTA). This is relevant when analyzing patents that are part of the same family, as seen in the case of Cellect LLC[1].

Inter Partes Review (IPR)

The Patent Trial and Appeal Board (PTAB) can review the validity of patent claims through Inter Partes Review. This process allows third parties to challenge the patentability of claims based on prior art, which can impact the validity and scope of the '947 patent[4].

Practical Implications

Strategic Patent Management

Understanding the scope and claims of the '947 patent is crucial for strategic patent management. This includes identifying gaps in coverage, determining future design opportunities, and making informed decisions about patent maintenance and enforcement[3].

Collaboration with Experts

Using tools like claim charts and collaborating with technical experts, engineers, and management can help in accurately analyzing the patent coverage and identifying areas for improvement or expansion[3].

Case Studies and Examples

Real-World Applications

To illustrate the importance of thorough claims analysis, consider a scenario where a company is developing a new product that may infringe on the claims of the '947 patent. A detailed analysis of the claims would help the company determine whether their product falls within the scope of the patent and whether they need to seek a license or modify their product to avoid infringement.

Key Takeaways

  • Claims Analysis: The claims of a patent define its scope and must be carefully analyzed to understand what is protected.
  • Patentability Requirements: Claims must meet novelty, nonobviousness, and subject matter eligibility requirements.
  • Patent Landscape: Analyzing the broader patent landscape helps in identifying competitor patents and gaps in coverage.
  • Legal Considerations: Understanding concepts like ODP and IPR is crucial for managing and enforcing patents.
  • Strategic Management: Accurate analysis of patent claims is essential for strategic patent management and future development.

FAQs

  1. What is the significance of independent and dependent claims in a patent? Independent claims define the invention broadly, while dependent claims narrow down the scope by adding specific details or limitations.

  2. How does the novelty requirement impact patent claims? The novelty requirement ensures that the claimed invention is new and not previously disclosed in the prior art.

  3. What is the role of a Claim Coverage Matrix in patent analysis? A Claim Coverage Matrix helps in categorizing patents by claims and scope concepts, identifying gaps or opportunities in patent coverage.

  4. How does Obviousness-Type Double Patenting (ODP) affect patent term? ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to PTA.

  5. What is the purpose of Inter Partes Review (IPR) in patent law? IPR allows third parties to challenge the patentability of claims based on prior art, which can impact the validity and scope of a patent.

Sources

  1. In re Cellect, LLC - United States Court of Appeals for the Federal Circuit[1].
  2. Patent Analytics - Intellectual Property Law[3].
  3. The Patent Trial and Appeal Board and Inter Partes Review - Congressional Research Service[4].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,704,947

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Abbvie LINZESS linaclotide CAPSULE;ORAL 202811-003 Jan 25, 2017 RX Yes Yes 7,704,947 ⤷  Subscribe Y Y ⤷  Subscribe
Abbvie LINZESS linaclotide CAPSULE;ORAL 202811-001 Aug 30, 2012 RX Yes Yes 7,704,947 ⤷  Subscribe Y Y ⤷  Subscribe
Abbvie LINZESS linaclotide CAPSULE;ORAL 202811-002 Aug 30, 2012 RX Yes No 7,704,947 ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,704,947

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1594517 ⤷  Subscribe 300593 Netherlands ⤷  Subscribe
European Patent Office 1594517 ⤷  Subscribe C300593 Netherlands ⤷  Subscribe
European Patent Office 1594517 ⤷  Subscribe CA 2013 00026 Denmark ⤷  Subscribe
European Patent Office 1594517 ⤷  Subscribe PA2013013 Lithuania ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.